| Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily, V Baldo, ... The Lancet 394 (10197), 497-509, 2019 | 1010 | 2019 |
| Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis M Drolet, É Bénard, MC Boily, H Ali, L Baandrup, H Bauer, S Beddows, ... The Lancet infectious diseases 15 (5), 565-580, 2015 | 893 | 2015 |
| Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study T Palmer, L Wallace, KG Pollock, K Cuschieri, C Robertson, K Kavanagh, ... bmj 365, 2019 | 304 | 2019 |
| Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study K Kavanagh, KG Pollock, K Cuschieri, T Palmer, RL Cameron, C Watt, ... The Lancet infectious diseases 17 (12), 1293-1302, 2017 | 286 | 2017 |
| Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types K Kavanagh, KGJ Pollock, A Potts, J Love, K Cuschieri, H Cubie, ... British journal of cancer 110 (11), 2804-2811, 2014 | 235 | 2014 |
| Reduction of low-and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland KGJ Pollock, K Kavanagh, A Potts, J Love, K Cuschieri, H Cubie, ... British journal of cancer 111 (9), 1824-1830, 2014 | 200 | 2014 |
| Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro H Sun, KGJ Pollock, JM Brewer Vaccine 21 (9-10), 849-855, 2003 | 198 | 2003 |
| Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles JM Brewer, KGJ Pollock, L Tetley, DG Russell The Journal of Immunology 173 (10), 6143-6150, 2004 | 167 | 2004 |
| Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009–2013 RL Cameron, K Kavanagh, J Pan, J Love, K Cuschieri, C Robertson, ... Emerging infectious diseases 22 (1), 56, 2016 | 148 | 2016 |
| The Leishmania mexicana cysteine protease, CPB2. 8, induces potent Th2 responses KGJ Pollock, KS McNeil, JC Mottram, RE Lyons, JM Brewer, P Scott, ... The Journal of Immunology 170 (4), 1746-1753, 2003 | 116 | 2003 |
| Interleukin‐18 plays a role in both the alum‐induced T helper 2 response and the T helper 1 response induced by alum‐adsorbed interleukin‐12 KGJ Pollock, M Conacher, XQ Wei, J Alexander, JM Brewer Immunology 108 (2), 137-143, 2003 | 110 | 2003 |
| Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes D Mesher, K Soldan, M Lehtinen, S Beddows, M Brisson, JML Brotherton, ... Emerging infectious diseases 22 (10), 1732, 2016 | 106 | 2016 |
| An outbreak of Cryptosporidium parvum across England & Scotland associated with consumption of fresh pre-cut salad leaves, May 2012 C McKerr, GK Adak, G Nichols, R Gorton, RM Chalmers, G Kafatos, ... PLoS One 10 (5), e0125955, 2015 | 100 | 2015 |
| Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England HL Bowyer, LAV Marlow, S Hibbitts, KG Pollock, J Waller Vaccine 31 (7), 1051-1056, 2013 | 99 | 2013 |
| Expression and characterization of a recombinant cysteine proteinase of Leishmania mexicana SJ SANDERSON, KGJ POLLOCK, JD HILLEY, M MELDAL, P ST HILAIRE, ... Biochemical Journal 347 (2), 383-388, 2000 | 92 | 2000 |
| Overcoming barriers in HPV vaccination and screening programs A Vorsters, M Arbyn, M Baay, X Bosch, S de Sanjosé, S Hanley, ... Papillomavirus Research 4, 45-53, 2017 | 89 | 2017 |
| Simultaneous increase of Cryptosporidium infections in the Netherlands, the United Kingdom and Germany in late summer season, 2012 N Fournet, MP Deege, AT Urbanus, G Nichols, BM Rosner, RM Chalmers, ... Eurosurveillance 18 (2), 20348, 2013 | 84 | 2013 |
| HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study TJ Palmer, M McFadden, KGJ Pollock, K Kavanagh, K Cuschieri, ... British journal of cancer 114 (5), 582-589, 2016 | 74 | 2016 |
| HPV status and favourable outcome in vulvar squamous cancer K Wakeham, K Kavanagh, K Cuschieri, D Millan, KG Pollock, S Bell, ... International journal of cancer 140 (5), 1134-1146, 2017 | 70 | 2017 |
| Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation D Mesher, K Cuschieri, S Hibbitts, J Jamison, A Sargent, KG Pollock, ... Journal of Clinical Pathology 68 (2), 135-140, 2015 | 63 | 2015 |
Kim KavanaghUniversity of StrathclydeVerified email at strath.ac.uk
